Ru360
Chemical compound
From Wikipedia, the free encyclopedia
Ru360 is an oxo-bridged dinuclear ruthenium ammine complex with an absorption spectrum maximum at 360 nm. It is an analog of ruthenium red, a well-known effective inhibitor of the mitochondrial calcium uniporter.[1]
| Names | |
|---|---|
| IUPAC name
azanide;formic acid;ruthenium(5+);trichloride;hydrate | |
| Other names
Ru360; (μ)[(HCO2)(NH3)4Ru]2OCl3; Obftar | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C2H26Cl3N8O5Ru2 | |
| Molar mass | 550.77 g·mol−1 |
| Appearance | Reddish brown solid |
| deoxygenated H2O | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Ru360 was discovered after scientists found that commercial preparations of ruthenium red were often less than 20% pure, and that the crude mixture produced a stronger inhibition than the purified product.[2] This component was later isolated and its structure determined,[1] Ru360 has structural formula (μ-O)[(HCO2)(NH3)4Ru]2Cl3, that is, an oxygen-linked chain only two octahedral ruthenium–ammine units rather than the three of ruthenium red. One of the ruthenium atoms is in a +3 oxidation state, and the other in a +4 oxidation state. In addition to the four ammonia ligands, each ruthenium also has one formate group and there are a total of three chloride ions to balance the charge. In solution, chloride or hydroxide groups displace the formates.[1]
Since Ru360 inhibits the flow of calcium into mitochondria, which can prevent the opening of the mitochondrial permeability transition pore, it has been investigated as a therapeutic treatment for stroke and heart attack.[3]